Related Experiment Video
Updated: Aug 20, 2026

An Improved Method for Rapid Intubation of the Trachea in Mice
Published on: February 22, 2016
Use of mitomycin C in the pediatric airway
1Department of Otolaryngology, University of California Davis Medical Center, Sacramento, California 95817, USA. cwsenders@ucdavis.edu
Purpose Of Review:
Mitomycin C was not used in the field of otolaryngology before 1998. Currently it is commonly used by all pediatric otolaryngologists dealing with airway stenoses. Mitomycin C offers the surgeon a method of modifying healing and diminishing granulation tissue and cicatricial scar.
Recent Findings:
There are numerous animal studies showing the beneficial effect of mitomycin C on wound healing in the airway. The human studies rarely have controls and in many cases are case reports. Human studies typically use dosages commonly used in ophthalmology, which are in the low range in relation to the animal airway studies.
Summary:
This article attempts to summarize the available research on mitomycin C, helping the clinical otolaryngologist choose the proper dosage, indications, and frequency of use.
Insights
Mitomycin C is now common in pediatric otolaryngology for airway stenosis, aiding wound healing and reducing scarring. This review guides clinicians on its optimal use, dosage, and frequency.
Area of Science:
- Otolaryngology
- Pediatric Otolaryngology
- Wound Healing
Background:
- Mitomycin C use in otolaryngology has increased significantly since 1998.
- It is now a common treatment for pediatric airway stenoses.
- The drug modifies healing and reduces granulation tissue and scar formation.
Purpose of the Study:
- To summarize current research on Mitomycin C in otolaryngology.
- To provide guidance on appropriate dosage, indications, and frequency of use.
- To support clinical decision-making for otolaryngologists treating airway stenoses.
Main Methods:
- Review of existing animal and human studies on Mitomycin C.
- Analysis of research on wound healing in the airway.
- Comparison of dosages used in ophthalmology versus airway studies.
Main Results:
- Animal studies demonstrate Mitomycin C's efficacy in airway wound healing.
- Human studies are often limited, lacking controls or consisting of case reports.
- Current human studies frequently use lower dosages than those tested in animal models.
Conclusions:
- Mitomycin C is a valuable tool for managing airway stenoses.
- Further controlled human studies are needed to establish optimal protocols.
- This review aims to assist clinicians in the safe and effective application of Mitomycin C.
Related Concept Videos
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Skeletal Muscle Relaxants: Therapeutic Uses
Cardiopulmonary Resuscitation II: ACLS Airway Management